Evidence map›Paper›PMID 32321927›Full record

ArticleScientific reports2020

A non-anhydrous, minimally basic protocol for the simplification of nucleophilic

J A H Inkster, V Akurathi, A W Sromek, Y Chen, J L Neumeyer, A B Packard

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Automation of Copper-MediatedMolecules (Basel, Switzerland) · 2024
    Article
  2. [Molecules (Basel, Switzerland) · 2023
    Article
  3. [Scientific reports · 2023
    Article
  4. Article
  5. Detrimental impact of aqueous mobile phases on 18F-labelled radiopharmaceutical analysisAnalytical methods : advancing methods and applications · 2023
    Article
  6. Article
  7. Nucleophilic Radiofluorination Using Tri-Molecules (Basel, Switzerland) · 2022
    Article
  8. SThe Journal of organic chemistry · 2021
    Article
  9. Article
  10. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J A H InksterDivision of Nuclear Medicine and Molecular Imaging, Boston Children's Hospital, Boston, MA, 02115, USA.
V AkurathiDivision of Nuclear Medicine and Molecular Imaging, Boston Children's Hospital, Boston, MA, 02115, USA.
A W SromekHarvard Medical School, Boston, MA, 02115, USA.
Y ChenHarvard Medical School, Boston, MA, 02115, USA.
J L NeumeyerHarvard Medical School, Boston, MA, 02115, USA.
A B PackardDivision of Nuclear Medicine and Molecular Imaging, Boston Children's Hospital, Boston, MA, 02115, USA. alan.packard@childrens.harvard.edu.ORCID http://orcid.org/0000-0003-0906-1021
Boston Children's Hospital · USHarvard University · US

Funding

A Novel F-18 PET Myocardial Perfusion Radiopharmaceutical based on Rhodamine DyesR01HL108107 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI PACKARD, ALAN BRENT · 2011 to 2020
$3.9M
F_18 Labeled D2 Agonist Ligands for PET Imaging of Dopaminergic DysfunctionR21MH103718 · NIMH · MCLEAN HOSPITAL · PI SROMEK, ANNA WACLAWA · 2014 to 2015
$507k
NHLBI NIH HHS R01 HL108107NIMH NIH HHS R21 MH103718
6 · The paper itself

Abstract

Fluorine-18 radiolabeling typically includes several conserved steps including elution of the [

Indexed as

HalogenationAnion Exchange ResinsBenzaldehydesChromatography, High Pressure LiquidFluorine RadioisotopesQuaternary Ammonium CompoundsSolventsAnion Exchange ResinsBenzaldehydesFluorine-18Fluorine RadioisotopesQuaternary Ammonium CompoundsSolvents

Identifiers

PMID32321927
PMCPMC7176689
OpenAlexW3018676765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.